Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Generics Priced At $4 Are “Much Ado About Nothing,” ABC Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Retail programs offering generics for $4 have had no impact on the wholesaler’s business, CEO Yost says.

You may also be interested in...

Wal-Mart’s Everywhere Low Prices

Roll out of $4 generic prescription drug program is complete, though some drugs in some states will cost $9.

McKesson Renews Distribution Deal With Wal-Mart

Wal-Mart says its new $4 generic prescription drug program did not impact negotiations.

Target Goes All In With $4 Generic Prescription Drug Program

Target’s program now available in 47 states, compared to 38 for Wal-Mart.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts